Biophage Pharma Inc.

International public company
6100 Royalmount, Montreal, CANPQ H4P 2R2, Canada
(514)4961452, (514)4961521 fax,

Primary SIC: Fluid Meters And Counting Devices, Primary NAICS: Totalizing Fluid Meter and Counting Device Manufacturing
Description: Biotechnology & pharmaceutical

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Biophage Pharma Inc., News and Information

Other News To Note.
BIOWORLD Today; 11/4/2009; 2138 words; ...2002.) Binoche Life Sciences Inc., of Belleville, Ontario, presented...Association meeting in Orlando, Fla. Biophage Pharma Inc., of Montreal, and its board...and chief scientific officer. Biophage is engaged in the development of...

This Essential Report on the Infectious Diseases Drugs Markets is Now Available.
M2 Presswire; 10/9/2009; 1202 words; ...Adlyfe, Inc - Advanced Life Sciences Holdings, Inc - Affinium Pharmaceuticals - Akonni Biosystems - Alnylam...Basilea Pharmaceutica AG - Baxter International, Inc - Biophage Pharma, Inc - CEL-SCI Corporation - Cerexa, Inc. (Subsidiary...

Research and Markets: This Essential Report on the Infectious Diseases Drugs Markets is Now Available.
Business Wire; 10/2/2009; 1120 words; ...Adlyfe, Inc * Advanced Life Sciences Holdings, Inc * Affinium Pharmaceuticals * Akonni Biosystems * Alnylam...Basilea Pharmaceutica AG * Baxter International, Inc * Biophage Pharma, Inc * CEL-SCI Corporation * Cerexa, Inc. (Subsidiary...

Albany College of Pharmacy and Health Sciences Receives $1.37 Million Grant to Assist in Development of Anthrax Antidote.
Bioterrorism Week; 2/2/2009; 1514 words; ...of Toronto, Rensselaer Polytechnic Institute and Biophage Pharma Inc. to develop an antidote ('antitoxin') for anthrax...efforts of PRI, University of Toronto, Rensselaer and Biophage Pharma, we hope to develop a drug that will offer a powerful...

TSX Venture Exchange Daily Bulletins for April 3, 2008.
Canadian Corporate News; 4/3/2008; 6265 words; ...Symbol Company Failure to File (Y/M/D) ( BUG ) Biophage Pharma Inc. Annual Financial Statements 07/11/30 Upon revocation...Symbole Societe Defaut de deposer (A/M/J) ( BUG ) Biophage Pharma Inc. Etats financiers annuels 07/11/30 Suite a l...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.